AUPH logo

Aurinia Pharmaceuticals (AUPH) Depreciation and amortization

annual D&A:

$19.45M+$7.80M(+66.95%)
December 31, 2024

Summary

  • As of today (June 1, 2025), AUPH annual depreciation & amortization is $19.45 million, with the most recent change of +$7.80 million (+66.95%) on December 31, 2024.
  • During the last 3 years, AUPH annual D&A has risen by +$16.68 million (+604.27%).
  • AUPH annual D&A is now at all-time high.

Performance

AUPH Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

quarterly D&A:

$4.86M-$6000.00(-0.12%)
March 31, 2025

Summary

  • As of today (June 1, 2025), AUPH quarterly depreciation & amortization is $4.86 million, with the most recent change of -$6000.00 (-0.12%) on March 31, 2025.
  • Over the past year, AUPH quarterly D&A has increased by +$9000.00 (+0.19%).
  • AUPH quarterly D&A is now -7.72% below its all-time high of $5.26 million, reached on September 30, 2023.

Performance

AUPH quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

TTM D&A:

$19.45M+$9000.00(+0.05%)
March 31, 2025

Summary

  • As of today (June 1, 2025), AUPH TTM depreciation & amortization is $19.45 million, with the most recent change of +$9000.00 (+0.05%) on March 31, 2025.
  • Over the past year, AUPH TTM D&A has increased by +$3.68 million (+23.31%).
  • AUPH TTM D&A is now -2.25% below its all-time high of $19.90 million, reached on June 30, 2024.

Performance

AUPH TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHincome statement metrics

AUPH Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+67.0%+0.2%+23.3%
3 y3 years+604.3%+479.5%+511.2%
5 y5 years+1560.5%+1529.5%+1691.3%

AUPH Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+618.6%-7.7%+2117.3%-2.3%+689.5%
5 y5-yearat high+1560.5%-7.7%+2117.3%-2.3%+1895.3%
alltimeall timeat high+2341.8%-7.7%+769.1%-2.3%+2342.8%

AUPH Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.86M(-0.1%)
$19.45M(+0.0%)
Dec 2024
$19.45M(+67.0%)
$4.86M(-0.6%)
$19.45M(-0.4%)
Sep 2024
-
$4.89M(+1.0%)
$19.53M(-1.9%)
Jun 2024
-
$4.84M(-0.1%)
$19.90M(+26.1%)
Mar 2024
-
$4.85M(-2.1%)
$15.78M(+35.5%)
Dec 2023
$11.65M(+330.4%)
$4.95M(-5.9%)
$11.65M(+68.4%)
Sep 2023
-
$5.26M(+631.8%)
$6.92M(+180.7%)
Jun 2023
-
$719.00K(+0.3%)
$2.46M(-4.7%)
Mar 2023
-
$717.00K(+227.4%)
$2.58M(-4.5%)
Dec 2022
$2.71M(-2.0%)
$219.00K(-72.9%)
$2.71M(-15.9%)
Sep 2022
-
$809.00K(-3.7%)
$3.22M(+1.4%)
Jun 2022
-
$840.00K(+0.2%)
$3.17M(-0.3%)
Mar 2022
-
$838.00K(+14.6%)
$3.18M(+15.3%)
Dec 2021
$2.76M(+101.4%)
$731.00K(-4.6%)
$2.76M(+13.2%)
Sep 2021
-
$766.00K(-9.7%)
$2.44M(+20.9%)
Jun 2021
-
$848.00K(+103.8%)
$2.02M(+35.5%)
Mar 2021
-
$416.00K(+1.5%)
$1.49M(+8.6%)
Dec 2020
$1.37M(+17.1%)
$410.00K(+19.2%)
$1.37M(+40.6%)
Sep 2020
-
$344.00K(+7.8%)
$975.00K(-4.4%)
Jun 2020
-
$319.00K(+7.0%)
$1.02M(-6.1%)
Mar 2020
-
$298.00K(+2028.6%)
$1.09M(-7.3%)
Dec 2019
$1.17M(-10.8%)
$14.00K(-96.4%)
$1.17M(-7.1%)
Sep 2019
-
$389.00K(+1.0%)
$1.26M(-1.5%)
Jun 2019
-
$385.00K(+0.5%)
$1.28M(-1.4%)
Mar 2019
-
$383.00K(+271.8%)
$1.30M(-1.2%)
Dec 2018
$1.31M(-9.8%)
$103.00K(-74.8%)
$1.31M(-16.4%)
Sep 2018
-
$408.00K(+1.2%)
$1.57M(+3.0%)
Jun 2018
-
$403.00K(+1.0%)
$1.52M(+2.2%)
Mar 2018
-
$399.00K(+10.5%)
$1.49M(+2.5%)
Dec 2017
$1.46M(-1.6%)
$361.00K(-0.3%)
$1.46M(-0.3%)
Sep 2017
-
$362.00K(-2.2%)
$1.46M(0.0%)
Jun 2017
-
$370.00K(+1.9%)
$1.46M(+0.3%)
Mar 2017
-
$363.00K(-0.5%)
$1.46M(-1.6%)
Dec 2016
$1.48M(-5.1%)
$365.00K(+0.8%)
$1.48M(+0.1%)
Sep 2016
-
$362.00K(-0.8%)
$1.48M(-4.6%)
Jun 2016
-
$365.00K(-5.7%)
$1.55M(+0.1%)
Mar 2016
-
$387.00K(+6.6%)
$1.55M(-0.7%)
Dec 2015
$1.56M(+2.4%)
$363.00K(-16.4%)
$1.56M(-2.9%)
Sep 2015
-
$434.00K(+19.6%)
$1.60M(+4.0%)
Jun 2015
-
$363.00K(-8.8%)
$1.54M(-0.4%)
Mar 2015
-
$398.00K(-2.9%)
$1.55M(+1.9%)
Dec 2014
$1.52M(+82.8%)
$410.00K(+9.9%)
$1.52M(-10.6%)
Sep 2014
-
$373.00K(+1.1%)
$1.70M(+20.9%)
Jun 2014
-
$369.00K(0.0%)
$1.41M(+25.8%)
Mar 2014
-
$369.00K(-37.6%)
$1.12M(+34.5%)
Dec 2013
$832.00K(-2.3%)
$591.00K(+648.1%)
$832.00K(+88.2%)
Sep 2013
-
$79.00K(-1.3%)
$442.20K(-25.5%)
Jun 2013
-
$80.00K(-2.4%)
$593.60K(-17.5%)
Mar 2013
-
$82.00K(-59.2%)
$719.90K(-15.4%)
Dec 2012
$851.40K(-11.4%)
$201.20K(-12.7%)
$851.40K(-7.3%)
Sep 2012
-
$230.40K(+11.7%)
$918.10K(+3.6%)
Jun 2012
-
$206.30K(-3.4%)
$886.00K(-4.9%)
Mar 2012
-
$213.50K(-20.3%)
$931.40K(-3.0%)
DateAnnualQuarterlyTTM
Dec 2011
$960.80K(-16.2%)
$267.90K(+35.1%)
$960.70K(+0.6%)
Sep 2011
-
$198.30K(-21.2%)
$954.80K(-4.4%)
Jun 2011
-
$251.70K(+3.7%)
$999.10K(-12.5%)
Mar 2011
-
$242.80K(-7.3%)
$1.14M(-0.5%)
Dec 2010
$1.15M(-6.6%)
$262.00K(+8.0%)
$1.15M(-3.6%)
Sep 2010
-
$242.60K(-38.4%)
$1.19M(-8.9%)
Jun 2010
-
$394.10K(+58.8%)
$1.31M(+12.7%)
Mar 2010
-
$248.20K(-18.6%)
$1.16M(-5.6%)
Dec 2009
$1.23M(-12.4%)
$304.80K(-15.1%)
$1.23M(-16.7%)
Sep 2009
-
$359.20K(+45.2%)
$1.48M(+15.7%)
Jun 2009
-
$247.40K(-21.9%)
$1.27M(-7.6%)
Mar 2009
-
$316.80K(-42.6%)
$1.38M(-1.7%)
Dec 2008
$1.40M(-20.5%)
$551.60K(+248.0%)
$1.40M(-20.3%)
Sep 2008
-
$158.50K(-54.9%)
$1.76M(-11.2%)
Jun 2008
-
$351.70K(+3.4%)
$1.98M(+0.3%)
Mar 2008
-
$340.00K(-62.6%)
$1.97M(+12.0%)
Dec 2007
$1.76M(-303.3%)
$907.90K(+139.0%)
$1.76M(+116.9%)
Sep 2007
-
$379.80K(+9.7%)
$812.70K(+29.3%)
Jun 2007
-
$346.20K(+168.0%)
$628.50K(-5128.0%)
Mar 2007
-
$129.20K(-404.0%)
-$12.50K(-98.6%)
Dec 2006
-$867.40K(-144.0%)
-$42.50K(-121.7%)
-$867.40K(+202.3%)
Sep 2006
-
$195.60K(-166.4%)
-$286.90K(-228.1%)
Jun 2006
-
-$294.80K(-59.4%)
$223.90K(-74.5%)
Mar 2006
-
-$725.70K(-234.9%)
$879.00K(-55.4%)
Dec 2005
$1.97M(-12.4%)
$538.00K(-23.8%)
$1.97M(-8.3%)
Sep 2005
-
$706.40K(+96.1%)
$2.15M(+12.3%)
Jun 2005
-
$360.30K(-1.6%)
$1.92M(-15.0%)
Mar 2005
-
$366.20K(-49.0%)
$2.25M(+0.1%)
Dec 2004
$2.25M(+68.4%)
$717.50K(+52.2%)
$2.25M(+12.6%)
Sep 2004
-
$471.30K(-32.4%)
$2.00M(+8.4%)
Jun 2004
-
$697.60K(+91.4%)
$1.84M(+27.0%)
Mar 2004
-
$364.50K(-21.8%)
$1.45M(+8.7%)
Dec 2003
$1.34M(+96.3%)
$465.90K(+47.5%)
$1.34M(+14.1%)
Sep 2003
-
$315.90K(+3.3%)
$1.17M(+21.8%)
Jun 2003
-
$305.90K(+23.0%)
$961.90K(+14.9%)
Mar 2003
-
$248.70K(-17.4%)
$836.90K(+22.9%)
Dec 2002
$680.90K(+105.7%)
$301.00K(+183.2%)
$681.00K(+79.2%)
Sep 2002
-
$106.30K(-41.2%)
$380.00K(+8.5%)
Jun 2002
-
$180.90K(+94.9%)
$350.30K(+46.2%)
Mar 2002
-
$92.80K(+21.1%)
$239.60K(-19.4%)
Dec 2001
$331.00K(-19.5%)
-
-
Aug 2001
-
$76.60K(+9.1%)
$297.40K(-23.2%)
May 2001
-
$70.20K(+76.8%)
$387.40K(+1.5%)
Feb 2001
-
$39.70K(-64.2%)
$381.80K(-7.1%)
Nov 2000
$411.00K(+101.8%)
$110.90K(-33.4%)
$411.00K(+11.1%)
Aug 2000
-
$166.60K(+157.9%)
$370.00K(+37.3%)
May 2000
-
$64.60K(-6.2%)
$269.40K(+30.6%)
Feb 2000
-
$68.90K(-1.4%)
$206.30K(+1.3%)
Nov 1999
$203.70K(-21.8%)
$69.90K(+5.9%)
$203.70K(+52.2%)
Aug 1999
-
$66.00K(+4300.0%)
$133.80K(+97.3%)
May 1999
-
$1500.00(-97.7%)
$67.80K(+2.3%)
Feb 1999
-
$66.30K
$66.30K
Nov 1998
$260.40K
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual D&A year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly D&A year-on-year change?
  • What is Aurinia Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM D&A year-on-year change?

What is Aurinia Pharmaceuticals annual depreciation & amortization?

The current annual D&A of AUPH is $19.45M

What is the all time high annual D&A for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual depreciation & amortization is $19.45M

What is Aurinia Pharmaceuticals annual D&A year-on-year change?

Over the past year, AUPH annual depreciation & amortization has changed by +$7.80M (+66.95%)

What is Aurinia Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of AUPH is $4.86M

What is the all time high quarterly D&A for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly depreciation & amortization is $5.26M

What is Aurinia Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, AUPH quarterly depreciation & amortization has changed by +$9000.00 (+0.19%)

What is Aurinia Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of AUPH is $19.45M

What is the all time high TTM D&A for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM depreciation & amortization is $19.90M

What is Aurinia Pharmaceuticals TTM D&A year-on-year change?

Over the past year, AUPH TTM depreciation & amortization has changed by +$3.68M (+23.31%)
On this page